Follow
Oliver Kepp
Oliver Kepp
INSERM UMR1138 / Gustave Roussy Cancer Center
Verified email at gustaveroussy.fr - Homepage
Title
Cited by
Cited by
Year
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
13149*2021
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ...
Cell Death & Differentiation 25 (3), 486-541, 2018
51142018
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
L Galluzzi, I Vitale, JM Abrams, ES Alnemri, EH Baehrecke, ...
Cell Death & Differentiation 19 (1), 107-120, 2012
31132012
Immunogenic cell death in cancer therapy
G Kroemer, L Galluzzi, O Kepp, L Zitvogel
Annual review of immunology 31, 51-72, 2013
29392013
Molecular mechanisms of cisplatin resistance
L Galluzzi, L Senovilla, I Vitale, J Michels, I Martins, O Kepp, M Castedo, ...
Oncogene 31 (15), 1869-1883, 2012
26562012
Immunogenic cell death in cancer and infectious disease
L Galluzzi, A Buqué, O Kepp, L Zitvogel, G Kroemer
Nature Reviews Immunology 17 (2), 97-111, 2017
22672017
Immunological effects of conventional chemotherapy and targeted anticancer agents
L Galluzzi, A Buque, O Kepp, L Zitvogel, G Kroemer
Cancer cell 28 (6), 690-714, 2015
14042015
Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice
M Michaud, I Martins, AQ Sukkurwala, S Adjemian, Y Ma, P Pellegatti, ...
Science 334 (6062), 1573-1577, 2011
13752011
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins, F Ghiringhelli, ...
Oncogene 29 (4), 482-491, 2010
11592010
Type I interferons in anticancer immunity
L Zitvogel, L Galluzzi, O Kepp, MJ Smyth, G Kroemer
Nature Reviews Immunology 15 (7), 405-414, 2015
11282015
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
L Galluzzi, BS Pedro, I Vitale, SA Aaronson, JM Abrams, D Adam, ...
Cell Death & Differentiation 22 (1), 58-73, 2015
11232015
Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
A Sistigu, T Yamazaki, E Vacchelli, K Chaba, DP Enot, J Adam, I Vitale, ...
Nature medicine 20 (11), 1301-1309, 2014
10042014
Decoding cell death signals in liver inflammation
C Brenner, L Galluzzi, O Kepp, G Kroemer
Journal of hepatology 59 (3), 583-594, 2013
9482013
Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death
T Panaretakis, O Kepp, U Brockmeier, A Tesniere, AC Bjorklund, ...
The EMBO journal 28 (5), 578-590, 2009
8872009
Consensus guidelines for the detection of immunogenic cell death
O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ...
Oncoimmunology 3 (9), e955691, 2014
8292014
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes
L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ...
Cell Death & Differentiation 16 (8), 1093-1107, 2009
8222009
Mitochondria: master regulators of danger signalling
L Galluzzi, O Kepp, G Kroemer
Nature reviews Molecular cell biology 13 (12), 780-788, 2012
7722012
Metabolic targets for cancer therapy
L Galluzzi, O Kepp, MGV Heiden, G Kroemer
Nature reviews Drug discovery 12 (11), 829-846, 2013
7522013
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ...
Journal for immunotherapy of cancer 8 (1), 2020
7382020
Immune parameters affecting the efficacy of chemotherapeutic regimens
L Zitvogel, O Kepp, G Kroemer
Nature reviews Clinical oncology 8 (3), 151-160, 2011
7282011
The system can't perform the operation now. Try again later.
Articles 1–20